Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 3Dermatologic 3Gynecologic 2Genitourinary 2CNS 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 27Ovarian Neoplasms 15Triple Negative Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 13Melanoma 10Neoplasm Metastasis 9Colorectal Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Urogenital Neoplasms 4Multiple Myeloma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Prostatic Neoplasms 2Osteosarcoma 2Lymphoma 2Liver Neoplasms 2Kidney Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 6Drug Therapy 3Cyclophosphamide 3spartalizumab 2fludarabine 2Sirolimus 2Riluzole 2Oncolytic Virotherapy 2Ipilimumab 2Blood Specimen Collection 2vofatamab 1tocilizumab 1saracatinib 1poly ICLC 1pertuzumab 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fludarabine phosphate 1enzalutamide 1durvalumab 1cediranib 1brodalumab 1atezolizumab 1aldesleukin 1advexin 1Ultrasonography 1Tissue Banks 1TKM-080301 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × fludarabine × Breast × Clear all
NCT07410494 2026-02-18

SELECT-CAR-NK

Essen Biotech

Phase 1/2 Recruiting
85 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT01967823 2021-03-24

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 12 charts
BreastCNSDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Melanoma, Meningioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡